Join us for an evening of Healthcare Tech innovation with Hartwig Medical Foundation and GCUG
Calling all software developers and tech enthusiasts 🚀
Hartwig Medical Foundation partners with Google Cloud User Group (GCUG) to bring you an exclusive event showcasing the cutting-edge technology behind our clinical impact in cancer research and diagnostics.
🔍 What to Expect:
At Hartwig, our mission revolves around making a significant difference in the treatment of cancer in the Netherlands. While many are familiar with our clinical achievements, it’s time to pull back the curtain on the technical setup that powers our work. Our open-source software is a cornerstone of our success, and we’re thrilled to share it with the tech community.
📅 Event Details:
🗓️ Date: 11th July
📍 Location: Hartwig Medical Foundation Office, Science Park 404, Amsterdam
🍽️ Agenda:
- 17:30 Doors open
- 18:00 Dinner and Drinks: Network with fellow tech enthusiasts over delicious food and beverages.
- 18:15 Welcome and Tech Talk by Korneel: Dive into ACTIN, our innovative system for end-to-end automated treatment decision support for patients with metastatic cancer.
- 19:00 Short break
- 19:15 Tech Talks by Matthijs and Mathijs: Explore how we manage and store massive amounts of genomics data.
- 20:00 Tech Quiz: Wrap up the evening with a fun tech quiz!
- 20:15 Drinks & sync
This is a great opportunity to learn about the intersection of healthcare and technology, network with like-minded professionals, and gain insights into the groundbreaking work happening at Hartwig.
👉 RSVP here and secure your spot for an inspiring evening💡
You read an article in the category Working in the cloud. You may also be interested in Education, Hartwig Medical Database, Hartwig Medical Foundation, IT, Personalized treatment All newsAlso read
In the media: Rarity – Personalised cancer treatment – fact not fiction
Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …
New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS
Oncode Institute has announced that the 13th grant within the Clinical Proof of Concept programme has been awarded. Oncode Investigator …
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients
Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …
In our profession, we need to know everything about the patient, but we also want to know as much as possible about the patient’s tumor.